According to Cognitive Market Research, the global Opioid Use Disorder market size was USD 2965.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 11.00% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 1186.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.2% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 889.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2031.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 682.00 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.0% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 148.26 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.4% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 59.30 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.7% from 2024 to 2031.
The buprenorphine category held the highest Opioid Use Disorder market revenue share in 2024.
